DK3145493T3 - Fremgangsmåder og sammensætninger vedrørende exosomer - Google Patents

Fremgangsmåder og sammensætninger vedrørende exosomer Download PDF

Info

Publication number
DK3145493T3
DK3145493T3 DK15796048.5T DK15796048T DK3145493T3 DK 3145493 T3 DK3145493 T3 DK 3145493T3 DK 15796048 T DK15796048 T DK 15796048T DK 3145493 T3 DK3145493 T3 DK 3145493T3
Authority
DK
Denmark
Prior art keywords
exosomes
methods
compositions relating
relating
compositions
Prior art date
Application number
DK15796048.5T
Other languages
English (en)
Inventor
S Alexander Mitsialis
Stella Kourembanas
Konstantinos Sdrimas
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Application granted granted Critical
Publication of DK3145493T3 publication Critical patent/DK3145493T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
DK15796048.5T 2014-05-18 2015-05-15 Fremgangsmåder og sammensætninger vedrørende exosomer DK3145493T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461994974P 2014-05-18 2014-05-18
PCT/US2015/031008 WO2015179227A1 (en) 2014-05-18 2015-05-15 Methods and compositions relating to exosomes

Publications (1)

Publication Number Publication Date
DK3145493T3 true DK3145493T3 (da) 2022-10-31

Family

ID=54554566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15796048.5T DK3145493T3 (da) 2014-05-18 2015-05-15 Fremgangsmåder og sammensætninger vedrørende exosomer

Country Status (11)

Country Link
US (2) US10624929B2 (da)
EP (1) EP3145493B1 (da)
JP (2) JP6773563B2 (da)
KR (1) KR20170005854A (da)
CN (2) CN106714781B (da)
AU (1) AU2015264519B2 (da)
CA (1) CA2949083C (da)
DK (1) DK3145493T3 (da)
ES (1) ES2929725T3 (da)
IL (1) IL249011B (da)
WO (1) WO2015179227A1 (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9901600B2 (en) 2011-03-11 2018-02-27 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
AU2014308751B2 (en) 2013-08-22 2020-03-05 Acceleron Pharma, Inc. TGF-beta receptor type II variants and uses thereof
EP4417255A3 (en) 2013-11-21 2024-10-23 The Brigham and Women's Hospital Inc. Compositions and methods for treating pulmonary hypertension
US10624929B2 (en) 2014-05-18 2020-04-21 Children's Medical Center Corporation Methods and compositions relating to exosomes
JP6955443B2 (ja) 2014-08-01 2021-10-27 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． 肺動脈性肺高血圧症の処置に関する方法および組成物
EP3226875B1 (en) * 2014-12-03 2020-05-27 Capricor, Inc. Processes for producing stable exosome formulations
MX2017013852A (es) * 2015-04-28 2019-04-15 Texas A & M Univ Sys Produccion escalable de vesiculas extracelulares estandarizadas, preparaciones de vesiculas extracelular y usos de estos.
US10702581B2 (en) 2015-05-04 2020-07-07 Ilias Biologics Inc. Compositions containing protein loaded exosome and methods for preparing and delivering the same
CN116327952A (zh) 2015-08-04 2023-06-27 阿塞勒隆制药公司 用于治疗骨髓增生性病症的方法
KR102805970B1 (ko) 2016-03-02 2025-05-09 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 매트릭스가 결합된 나노소낭 및 그의 용도
EP3423070B1 (en) * 2016-03-03 2022-05-04 Henry Ford Health System 3-d collagen scaffold-generated exosomes and uses thereof
CN105861430B (zh) * 2016-04-29 2019-07-23 南京大学 一种外泌体、外泌体的制备方法及其在制备治疗脓毒症药物或者制剂中的应用
US10946047B2 (en) 2016-06-17 2021-03-16 United Therapeutics Corporation Extracellular vesicles with enhanced potency
CA3027970A1 (en) * 2016-06-17 2017-12-21 United Therapeutics Corporation Extracellular vesicles with enhanced potency
WO2018025973A1 (ja) 2016-08-03 2018-02-08 国立大学法人名古屋大学 多能性幹細胞による慢性肺疾患の改善及び治療
EP3494977A4 (en) * 2016-08-05 2020-03-18 Exostemtech Co., Ltd. COMPOSITION FOR THE PREVENTION OR TREATMENT OF LUNG FIBROSE WITH FAT TISSUE EXOSOM OBTAINED FROM STEM CELLS AS AN ACTIVE SUBSTANCE
US11596656B2 (en) 2016-08-23 2023-03-07 Albert Einstein College Of Medicine Stem cell-produced microvesicles for treating tendon pathologies
CA3002520A1 (en) * 2016-09-30 2018-04-05 Ilias Biologics Inc. Compositions containing protein loaded exosome and methods for preparing and delivering the same
WO2018085587A1 (en) * 2016-11-02 2018-05-11 Prockop Darwin J Exosomes and uses thereof in diseases of the brain
EP3568143B1 (en) * 2017-01-11 2023-12-13 Paracelsus Medizinische Privatuniversität Salzburg - Privatstiftung Mesenchymal stem cell-derived extracellular vesicles and their medical use
KR101973284B1 (ko) * 2017-01-16 2019-04-29 사회복지법인 삼성생명공익재단 신생아 ｈｉｅ 치료용 조성물
CN110520140A (zh) * 2017-04-19 2019-11-29 菲格内有限责任公司 成纤维细胞衍生的外泌体刺激血管生成
CN107137700B (zh) * 2017-04-27 2021-01-12 张国瑜 一种基于干细胞源外泌体的组合物及其在制备治疗心肌梗死的药物中的应用
BR112019023071A2 (pt) 2017-05-04 2020-06-09 Acceleron Pharma Inc proteínas de fusão do receptor tgf-beta do tipo ii e uso das mesmas
US11638724B2 (en) 2017-05-05 2023-05-02 University of Pittsburgh—of the Commonwealth System of Higher Education Ocular applications of matrix bound vesicles (MBVs)
WO2019004757A2 (ko) * 2017-06-30 2019-01-03 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 가려움증 억제 또는 개선 용도
CN107349220A (zh) * 2017-07-26 2017-11-17 深圳市泰华细胞工程有限公司 一种包含成纤维细胞外泌体的制剂及其用途
US20220023347A9 (en) * 2017-08-15 2022-01-27 Children's Medical Center Corporation Purified mesenchymal stem cell exosomes and uses thereof
WO2019083201A2 (ko) * 2017-10-24 2019-05-02 주식회사 엑소코바이오 지방줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 신장 기능 개선 용도
GB201718681D0 (en) * 2017-11-13 2017-12-27 Evox Therapeutics Ltd Protein engineered extracellular vesicles
WO2019118817A1 (en) * 2017-12-14 2019-06-20 Mayo Foundation For Medical Education And Research Purified exosome products, method of making, and methods of using
CN108318688B (zh) * 2018-01-10 2019-08-06 浙江大学 外周血外泌体中Smad3蛋白作为分子标记的应用、肝癌检测试剂盒
WO2019168977A1 (en) * 2018-02-27 2019-09-06 Musc Foundation For Research Development Compositions and methods for treating and/or preventing sepsis and/or inflammatory conditions
AU2019242912B2 (en) 2018-03-28 2025-07-17 Board Of Regents, The University Of Texas System Identification of epigenetic alterations in DNA isolated from exosomes
KR102015502B1 (ko) 2018-03-29 2019-08-28 아키소스템바이오스트래티지스(주) 인간 제대로부터 줄기세포를 분리하는 방법
JP2021520790A (ja) 2018-04-10 2021-08-26 ブレインストーム セル セラペウティクス リミテッド 細胞型特異的エキソソームおよびそれらの使用
AU2019255765B2 (en) * 2018-04-19 2025-02-06 Board Of Regents, The University Of Texas System Therapeutic modulation of tumor suppressors using exosomes
US12521418B2 (en) 2018-04-30 2026-01-13 Children's Medical Center Corporation Mesenchymal stromal cell exosomes and uses thereof
EP3787642A4 (en) * 2018-05-03 2022-09-21 University of Pittsburgh - of the Commonwealth System of Higher Education IL-33 CONTAINING MATRIX-BONDED VESICLES (MBVS) AND THEIR USE
CN108865985A (zh) * 2018-06-22 2018-11-23 山东省职业卫生与职业病防治研究院 一种干细胞源外泌体干预上皮-间质转化的方法
CN109266603A (zh) * 2018-08-29 2019-01-25 浙江大学 一种提高心梗疗效的外泌体及应用
CN110876734A (zh) * 2018-09-06 2020-03-13 杨昆德 包含胞外囊泡的制剂、用以制备该制剂的方法及其用途
CN109596841B (zh) * 2019-01-14 2020-04-14 浙江大学 外泌体TβRII蛋白作为标志物在制备乳腺癌检测试剂盒中的应用
KR102300686B1 (ko) 2019-02-15 2021-09-08 이귀선 모터 포인트의 전기 자극으로 발생된 근전도 신호를 감지하여 운동점을 확인할 수 있는 근전도 탐지부를 포함하는 근감소증치료 전기근육자극 장치
CN110115769A (zh) * 2019-04-08 2019-08-13 浙江大学 一种脑靶向外泌体及其制备方法和应用
WO2020231700A1 (en) * 2019-05-11 2020-11-19 Youngsuk Yi Neurotoxin compositions and methods
TW202122569A (zh) * 2019-08-09 2021-06-16 日商宇部興產股份有限公司 應用小片多孔膜的細胞培養法
TWI787697B (zh) 2019-12-30 2022-12-21 財團法人工業技術研究院 外泌體的分離方法、膠體粒子及其製備方法
US12508287B2 (en) 2020-02-13 2025-12-30 Spinalcyte Llc Treatment of cerebral palsy using fibroblasts
WO2021167879A1 (en) * 2020-02-17 2021-08-26 Spinalcyte, Llc Telomere length modulation using fibroblasts
WO2021202032A1 (en) * 2020-04-01 2021-10-07 Figene, Llc Fibroblast mediated expansion and augmentation of immune regulatory cells for treatment of acute respiratory distress syndrome (ards)
WO2021207192A1 (en) * 2020-04-08 2021-10-14 Figene, Llc Methods and compositions for allergy and asthma treatment using fibroblasts
JP6967308B1 (ja) * 2020-06-30 2021-11-17 国立大学法人高知大学 胎児付属物由来組織細胞培養上清を含む脳神経障害治療剤
CN114377215B (zh) * 2020-10-16 2023-01-31 生物岛实验室 界面修饰的疝气片及其制备方法
US20230112339A1 (en) 2020-10-30 2023-04-13 Vitti Labs Mesenchymal stem cell compositions and methods of making
CN115212234B (zh) * 2021-10-22 2023-11-10 武汉大学中南医院 纤维网状细胞来源的外泌体在制备用于治疗和/或预防脓毒症急性肾损伤的药物中的应用
WO2023182507A1 (ja) * 2022-03-24 2023-09-28 北海道公立大学法人 札幌医科大学 薬学的組成物、間葉系幹細胞の三次元培養物の製造方法、エクソソームの製造方法、および薬学的組成物の製造方法
CN115109741A (zh) * 2022-05-17 2022-09-27 华中农业大学 一种脂质筏的快速分离方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US20040214783A1 (en) 2002-05-08 2004-10-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US8021847B2 (en) * 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
WO2006110582A1 (en) 2005-04-08 2006-10-19 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
US20080199849A1 (en) 2005-09-02 2008-08-21 Agency For Science, Technology And Research Method of Deriving Progenitor Cell Line
JP2010500047A (ja) 2006-08-15 2010-01-07 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 間葉系幹細胞馴化培地
ES2583371T3 (es) 2006-10-11 2016-09-20 The General Hospital Corporation Composiciones, métodos, y dispositivos para tratar enfermedades hepáticas
EP1944361A1 (en) 2007-01-11 2008-07-16 INSERM (Institut National de la Santé et de la Recherche Médicale) A method for expanding monocytes
WO2009087361A1 (en) 2008-01-04 2009-07-16 Lydac Neuroscience Limited Microvesicles
PL2254586T3 (pl) 2008-02-22 2015-09-30 Agency For Science Tech And Research Astarstar Cząstki mezenchymalnych komórek macierzystych
SG10201403202XA (en) 2009-07-23 2014-08-28 Agency Science Tech & Res Pre-natal mesenchymal stem cells
CN102858997B (zh) 2009-11-02 2014-06-18 新加坡科技研究局 用于监测细胞状态和用于永生间充质干细胞的方法
KR101189655B1 (ko) 2010-06-30 2012-10-11 성균관대학교산학협력단 줄기세포 배양액을 포함하는 폐질환 치료용 조성물
CN101890050B (zh) 2010-07-14 2012-07-04 江苏大学 脐带间质干细胞来源膜性囊泡及其应用
CA2845280A1 (en) 2010-08-13 2012-02-16 Paul Shiels Therapeutic uses of microvesicles and related micrornas
WO2012115885A1 (en) 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
US9901600B2 (en) 2011-03-11 2018-02-27 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
KR20140072014A (ko) * 2011-06-16 2014-06-12 카리스 라이프 사이언스 룩셈부르크 홀딩스, 에스.에이.알.엘. 생물지표 조성물 및 방법
ITTO20111183A1 (it) 2011-12-21 2013-06-22 Univ Degli Studi Torino Mezzo condizionato ottenuto da cellule staminali mesenchimali placentari e suo uso nel trattamento terapeutico della preeclampsia
US9427450B2 (en) 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
JP6450673B2 (ja) * 2012-04-03 2019-01-09 リニューロン・リミテッドＲｅＮｅｕｒｏｎ Ｌｉｍｉｔｅｄ 幹細胞微粒子
KR101399056B1 (ko) * 2012-04-16 2014-05-27 연세대학교 산학협력단 줄기세포-유래 미세소포체를 유효성분으로 포함하는 신경질환 예방 또는 치료용 약제학적 조성물
WO2014028763A1 (en) 2012-08-15 2014-02-20 The University Of Chicago Exosome-based therapeutics against neurodegenerative disorders
CN105142646A (zh) 2013-02-12 2015-12-09 兰诺龙有限公司 产生微粒的方法
SG11201508433TA (en) 2013-04-12 2015-11-27 Andaloussi Samir El Therapeutic delivery vesicles
EP3030537B1 (de) 2013-08-07 2017-12-13 PI Ceramic GmbH Piezokeramischer werkstoff mit reduziertem bleigehalt
WO2016043654A1 (en) 2014-09-15 2016-03-24 Agency For Science, Technology And Research Methods of treating graft versus host disease (gvhd) or epidermolysis bullosa (eb) with exosomes
SG11201601939VA (en) 2013-09-16 2016-04-28 Agency Science Tech & Res Method
US10624929B2 (en) 2014-05-18 2020-04-21 Children's Medical Center Corporation Methods and compositions relating to exosomes
CN105769916B (zh) 2016-04-29 2019-07-23 南京大学 间充质干细胞来源外泌体在制备治疗子痫前期药物或者制剂中的应用
CA3027970A1 (en) 2016-06-17 2017-12-21 United Therapeutics Corporation Extracellular vesicles with enhanced potency
KR101973284B1 (ko) 2017-01-16 2019-04-29 사회복지법인 삼성생명공익재단 신생아 ｈｉｅ 치료용 조성물
US11760975B2 (en) 2017-03-31 2023-09-19 Wisconsin Alumi Research Foundation Generation of therapeutic cells using extracellular components of target organs
US20220023347A9 (en) 2017-08-15 2022-01-27 Children's Medical Center Corporation Purified mesenchymal stem cell exosomes and uses thereof
US12521418B2 (en) 2018-04-30 2026-01-13 Children's Medical Center Corporation Mesenchymal stromal cell exosomes and uses thereof
CA3099042A1 (en) 2018-05-09 2019-11-14 Children's Medical Center Corporation Mesenchymal stromal cell exosome -treated monocytes and uses thereof
CA3111661A1 (en) 2018-09-05 2020-03-12 Children's Medical Center Corporation Use of mesenchymal stromal cell exosomes in antenatal therapy

Also Published As

Publication number Publication date
AU2015264519A1 (en) 2016-12-15
EP3145493A1 (en) 2017-03-29
AU2015264519B2 (en) 2021-01-28
US11759481B2 (en) 2023-09-19
KR20170005854A (ko) 2017-01-16
CN106714781B (zh) 2021-08-10
CN106714781A (zh) 2017-05-24
US20170258840A1 (en) 2017-09-14
CA2949083A1 (en) 2015-11-26
EP3145493A4 (en) 2018-05-30
CA2949083C (en) 2023-10-10
CN113817672A (zh) 2021-12-21
IL249011A0 (en) 2017-01-31
ES2929725T3 (es) 2022-12-01
JP2021020908A (ja) 2021-02-18
JP2017517505A (ja) 2017-06-29
US20200281983A1 (en) 2020-09-10
US10624929B2 (en) 2020-04-21
EP3145493B1 (en) 2022-07-27
WO2015179227A1 (en) 2015-11-26
IL249011B (en) 2021-12-01
JP6773563B2 (ja) 2020-10-21

Similar Documents

Publication Publication Date Title
IL249011A0 (en) Methods and preparations related to exosomes
KR20180084891A (ko) 구조 조성물 및 방법
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3169741T3 (da) Forbedrede bindemiddelsammensætninger og anvendelser deraf
DK3169733T3 (da) Forbedrede bindemiddelsammensætninger og anvendelser deraf
DK3221363T3 (da) Antistoffer mod cd73 og anvendelser deraf
DK3015526T3 (da) Hydrofluorolefinbaseret sammensætning og anvendelse deraf
DK3130649T3 (da) Haloolefin-baseret sammensætning
DK3542812T3 (da) Glycopeptidsammensætninger
LT3102555T (lt) Junginių kompozicijos ir jų panaudojimas
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
FR3024363B1 (fr) Composition thermogelifiable
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
DK3324932T3 (da) Sammensætninger og fremgangsmåder for nanopartikel lyofile former
PL3154515T3 (pl) Udoskonalenia kompozycji donosowych i sposób ich stosowania
DK3212776T3 (da) Sammensætninger og fremgangsmåder i forbindelse med beta-glucosidase
DK3129007T3 (da) Vaccinesammensætninger
CL2017000639A1 (es) Composición
IL257458B1 (en) Dpep-1 binding compositions and methods of use
HUE070090T2 (hu) Összetétel
DK3223846T3 (da) Adjuvanssammensætninger og tilhørende fremgangsmåder
DK3166960T3 (da) Lav-substituerede polymyxiner og sammensætninger deraf
DK3200827T3 (da) Sammensætninger
DK3099314T3 (da) Tolerogene sammensætninger og anvendelser deraf
DK3068428T3 (da) Annexin-ii-variant-sammensætninger og fremgangsmåder